01-06-2019 | Research Article
Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study
Published in: Frontiers of Medicine | Issue 3/2019
Login to get access